Lamotrigine, sold as Lamictal, stands out among anticonvulsant and mood-stabilizing drugs for having one of the more brain-friendly long-term profiles. Unlike several older seizure medications that are notorious for dulling thinking and memory, lamotrigine appears to preserve cognitive function and may even protect brain cells from damage over time. That does not mean years on the drug leave the brain completely unchanged, though. Research points to measurable shifts in brain metabolism, structure, sleep patterns, and even gene expression, and the picture varies depending on age, diagnosis, and what other medications are in the mix.
How Lamotrigine Acts on Brain Cells
Lamotrigine works primarily by blocking voltage-gated sodium channels on nerve cells. When these channels are partially shut down, neurons fire less erratically, which is why the drug controls seizures. But there is a downstream effect that matters more for long-term brain health: by calming those sodium channels, lamotrigine reduces the release of glutamate, the brain’s main excitatory chemical messenger.1Neuropharmacology. Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings Glutamate in excess is toxic to neurons, a process called excitotoxicity, and keeping it in check appears to be one reason lamotrigine has neuroprotective properties that go beyond simply stopping seizures.2PubMed Central. Understanding Lamotrigine’s Role in the CNS and Possible Future Evolution
Cognitive Function Over Years of Use
One of the most common fears people have about staying on any brain-active medication long-term is whether it will make them feel mentally dull. With lamotrigine, the evidence is reassuring. A systematic review of cognitive studies found that the thinking problems commonly linked to seizure medications are not typically seen in people taking lamotrigine alone. When lamotrigine is added to another medication, existing cognitive difficulties are generally not worsened and in some cases clearly improve.3Epilepsy & Behavior. A Systematic Review of the Effects of Lamotrigine on Cognitive Function and Quality of Life
Head-to-head comparisons reinforce the point. In a study of older adults with epilepsy, lamotrigine had less impact on verbal fluency and graphomotor speed than topiramate, while topiramate performed somewhat better on delayed memory recall.4PubMed Central. Cognitive effects of lamotrigine versus topiramate as adjunctive therapy in older adults with epilepsy A separate comparison described lamotrigine as exhibiting “a desirable cognitive profile with no apparent cognitive deteriorations,” in contrast to topiramate, which has substantial evidence of negative effects on executive functions.5Epilepsy & Behavior. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting
People with bipolar disorder often report a subjective sense of “brain fog” on their medication regimens. When researchers looked at what happened after patients switched to lamotrigine, self-reported cognitive scores improved dramatically. Among depressed patients who took lamotrigine as their only medication, scores on a cognitive functioning scale rose by about 80 percent from baseline, and scores on a scale measuring perceived cognitive deficits dropped by roughly half.6PubMed. Effect of lamotrigine on cognitive complaints in patients with bipolar I disorder Some of that improvement likely reflects the fact that depression itself clouds thinking, so as mood lifts, cognition follows. Still, the pattern is consistent: lamotrigine rarely adds a cognitive burden and sometimes lightens one.
Neuroprotection Against Glutamate Damage
Beyond simply not harming the brain, there is laboratory evidence that lamotrigine actively protects it. In cell-culture experiments, pretreating neurons with lamotrigine for three days was enough to provide full protection against glutamate-induced cell death. The drug blocked excitotoxicity in a dose-dependent way, meaning higher concentrations offered more protection, with results confirmed by multiple measures of cell survival.7PubMed Central. Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction
Animal studies tell a similar story. In gerbils subjected to a model of stroke-like brain injury, lamotrigine given either before or after the event produced significant protection of neurons, confirmed at both one week and four weeks later. Animals treated with lamotrigine also recovered better on behavioral tests, and researchers confirmed that the drug dampened the surge of glutamate that typically follows loss of blood flow to the brain.8Brain Research. Neuroprotective effects of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioral study
Lamotrigine also appears to support brain-derived neurotrophic factor (BDNF), a protein that helps neurons grow, survive, and form new connections. In animal experiments, chronic lamotrigine treatment raised BDNF levels in the frontal cortex and hippocampus, even restoring BDNF that had been depleted by chronic stress.9International Journal of Neuropsychopharmacology. Brain-derived neurotrophic factor signalling mediates antidepressant effects of lamotrigine A broader review confirmed that lamotrigine is among several seizure medications that can influence neuroplasticity, the brain’s ability to rewire and adapt.10PubMed Central. Brain Neuroplasticity after Treatment with Antiseizure: A Review This combination of protecting existing neurons and encouraging new connections is part of why researchers have looked at lamotrigine for conditions well beyond epilepsy.
Anti-Inflammatory Effects in the Brain
Chronic inflammation in the brain is increasingly recognized as a contributor to neurodegenerative diseases and mood disorders. Lamotrigine appears to dial down several inflammatory signals. In a mouse model of Alzheimer’s disease, lamotrigine treatment significantly reduced levels of the inflammatory molecules IL-6 and IL-1β in brain tissue and suppressed the activation of astrocytes, a type of brain cell that can drive inflammation when overactive.11PubMed Central. Lamotrigine Reduces Inflammatory Response and Ameliorates Executive Function Deterioration in an Alzheimer’s-Like Mouse Model
A separate study using a broader inflammation model confirmed that lamotrigine suppressed the release of IL-1β, IL-6, and TNF-α in living animals and in isolated immune cells. The researchers noted this was particularly relevant because monocytes that infiltrate the brain are increasingly seen as players in neuroinflammation.12Journal of Neuroimmunology. Effect of lamotrigine on in vivo and in vitro cytokine secretion in murine model of inflammation Whether these anti-inflammatory effects translate into measurable protection against dementia or neurodegeneration in humans is still an open question, but the laboratory signals are encouraging.
What Brain Scans Show
Neuroimaging studies reveal that lamotrigine does produce measurable changes in how the brain uses energy and, in some cases, in the physical size of certain brain structures. In people with epilepsy, PET scans taken before and after starting lamotrigine showed decreased glucose metabolism across multiple brain regions, including parts of the temporal and parietal lobes, the thalamus, caudate nuclei, and frontal cortex. No brain regions showed increased metabolism.13JAMA Neurology. Regional Effects of Lamotrigine on Cerebral Glucose Metabolism in Idiopathic Generalized Epilepsy A separate comparison found that lamotrigine decreased cortical metabolism more than it affected deep brain structures, while topiramate followed the opposite pattern.14American Epilepsy Society. THE EFFECTS OF LAMOTRIGINE AND TOPIRAMATE ON CEREBRAL GLUCOSE METABOLISM
A drop in brain glucose metabolism sounds alarming, but context matters. The whole point of the drug is to reduce excessive neural firing. The metabolic decreases likely reflect neurons that are no longer burning through fuel at abnormally high rates, not neurons that are starving. In older adults with bipolar depression, adding lamotrigine did not produce any significant change in cerebral metabolic markers, suggesting the effect may be most pronounced when the brain starts from a hyperactive baseline.15The American Journal of Geriatric Psychiatry. Lamotrigine Therapy and Biomarkers of Cerebral Energy Metabolism in Older Age Bipolar Depression
On the structural side, people with bipolar disorder who responded well to lamotrigine showed decreased volumes in the amygdala, cerebellum, and nucleus accumbens. Researchers interpreted these changes as potentially linked to the drug’s antidepressant effects, since those regions are heavily involved in mood and emotional regulation.16Psychiatry Research: Neuroimaging. Changes in amygdala, cerebellum, and nucleus accumbens volumes in bipolar patients treated with lamotrigine In a different context, a randomized trial looking at whether lamotrigine could protect the hippocampus from corticosteroid-induced damage found no significant difference in hippocampal volumes between the lamotrigine and placebo groups.17European Neuropsychopharmacology. A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus The structural picture, in other words, depends on who is taking the drug and why.
Long-Term Mood Stabilization
For people with bipolar disorder, the most important long-term brain effect of lamotrigine may simply be that it keeps working. A meta-analysis of maintenance treatment trials found that lamotrigine was associated with significantly lower relapse rates compared to placebo. Relapse rates were statistically comparable to those seen with lithium, and higher-quality registry studies linked lamotrigine to lower hospital admission rates than other commonly used treatment regimens.18PubMed. The efficacy of lamotrigine in bipolar disorder: A systematic review and meta-analysis Because each mood episode carries its own risk of brain changes and cognitive damage, preventing those episodes is itself a form of neuroprotection over the years.
Effects on Sleep
Sleep is when the brain does much of its repair and memory consolidation, so any long-term medication that disrupts sleep architecture could indirectly harm the brain. Lamotrigine’s track record here is mixed but generally favorable. In people with epilepsy, lamotrigine decreased deep slow-wave sleep and increased lighter stage 2 sleep, but it also reduced arousals, reduced stage shifts (the restless bouncing between sleep stages), and increased REM periods.19PubMed. The effects of lamotrigine on sleep in patients with epilepsy Crucially, daytime sleepiness scores did not change, which suggests the sleep that people did get was more consolidated even if its architecture shifted somewhat.20PubMed Central. Effects of antiepileptic drugs on sleep architecture parameters in adults
The reduction in slow-wave sleep is worth noting because that stage is associated with memory consolidation and cellular repair. Whether the modest decrease observed in studies has meaningful consequences over years of use is unclear. Many people on lamotrigine report sleeping better than they did on other anticonvulsants, and the drug is generally considered less disruptive to sleep than older alternatives.
Children and Developing Brains
The developing brain is especially vulnerable to drug effects, which is why the cognitive profile of any pediatric medication gets extra scrutiny. Long-term studies in children with epilepsy have been reassuring. In one study following pediatric patients for an average of about two years, lamotrigine was well tolerated as either a sole therapy or an add-on.21PubMed. Long-term tolerability and efficacy of lamotrigine in pediatric patients with epilepsy A study of 119 children treated long-term confirmed a neutral cognitive profile, concluding that lamotrigine seemed especially suitable for pediatric epilepsy precisely because developing brains are more susceptible to the cognitive side effects of other seizure drugs.22European Journal of Paediatric Neurology. Long-term profile of lamotrigine in 119 children with epilepsy
A review of the broader evidence on seizure medications in children and adolescents found that lamotrigine was associated with improvements in some cognitive areas, though the authors noted it was hard to separate the direct drug effect from the benefit of having fewer seizures.23PubMed. Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy That ambiguity runs through much of the pediatric literature, but the key takeaway is that lamotrigine does not appear to impair neurodevelopment even over extended use.
Prenatal Exposure
For women who take lamotrigine during pregnancy, the question shifts to whether the drug affects the developing brain of the fetus. A systematic review and meta-analysis found that prenatal exposure to lamotrigine monotherapy was not statistically associated with neurodevelopmental disorders as a whole, including language disorders, autism spectrum disorder, or ADHD. There was a signal for increased risk of psychomotor delay and cognitive delay in children under three, but these findings came exclusively from observational studies with known biases and very small numbers of children.24PubMed Central. Neurodevelopmental outcomes after prenatal exposure to lamotrigine monotherapy in women with epilepsy: a systematic review and meta-analysis The potential delays in the youngest age groups did not persist in older children.
A separate follow-up study tracked children exposed to lamotrigine in the womb up to age twelve, with over half of the children being between six and twelve at the time of evaluation. No significant increase in the incidence of neurodevelopmental disorders was found.25PubMed Central. Short- and long-term complications of in utero exposure to lamotrigine This is one reason lamotrigine is widely considered one of the safer seizure medications during pregnancy, though the decision always involves weighing the risks of uncontrolled seizures against any drug exposure.
Older Adults
The aging brain has less reserve to absorb medication side effects, and older adults metabolize drugs differently. Lamotrigine’s profile in this population is generally favorable. In elderly patients with epilepsy, the rate of drug-related side effects was significantly lower with lamotrigine than with carbamazepine or phenytoin. Sedation, a particular concern in older adults because it raises fall risk, occurred at half the rate seen with carbamazepine.26PubMed. The tolerability of lamotrigine in elderly patients with epilepsy The same systematic review that reported lamotrigine’s favorable cognitive profile across ages specifically noted it was well tolerated in the elderly.3Epilepsy & Behavior. A Systematic Review of the Effects of Lamotrigine on Cognitive Function and Quality of Life
Rare Motor Side Effects
Most discussions of lamotrigine’s brain effects focus on cognition and mood, but the motor system deserves mention. Tremor is a known side effect when lamotrigine is combined with valproic acid, though tremor with lamotrigine alone is rare.27PubMed Central. Action tremor associated with lamotrigine monotherapy When the two drugs are combined, the risk goes up because valproic acid slows the breakdown of lamotrigine, effectively raising its levels in the body. Case reports describe disabling tremor that resolved after adjusting doses.28PubMed Central. Disabling tremor induced by long-term use of sodium valproate and lamotrigine Involuntary jerky movements, known as chorea, have been reported very rarely with lamotrigine, typically when other centrally acting medications are also on board.29PubMed Central. Chorea Associated with Lamotrigine Use For people taking lamotrigine alone at standard doses, significant motor side effects are uncommon.
What Happens When You Stop
Any long-term medication that changes brain activity can produce withdrawal effects if stopped abruptly. Lamotrigine is no exception. Sudden cessation of drugs used in neurological and psychiatric conditions can cause withdrawal syndrome, discontinuation syndrome, or rebound effects, characterized by various physical and psychological symptoms that tend to appear quickly but are usually limited in duration.30PubMed. Rebound effect, discontinuation, and withdrawal syndromes associated with drugs used in psychiatric and neurological disorders For lamotrigine specifically, the most significant risk of abrupt withdrawal is seizure recurrence in people with epilepsy, since the suppressive effect on neural excitability disappears. Gradual tapering, typically over at least two weeks, is standard practice to minimize rebound effects.
Epigenetic and Hormonal Shifts
Some of lamotrigine’s longer-term effects on the brain may operate through changes in how genes are read and expressed. Research has shown that lamotrigine increases the acetylation of histone H3, a chemical modification that opens up DNA for gene transcription, and moderately decreases histone deacetylase activity. It also raises levels of Bcl-2, a protein that protects cells from programmed death, in a dose-dependent way.31Frontiers in Pharmacology. Dissecting the Epigenetic Changes Induced by Non-Antipsychotic Mood Stabilizers on Schizophrenia and Affective Disorders: A Systematic Review These epigenetic shifts could partly explain both the neuroprotective and mood-stabilizing effects of the drug, since Bcl-2 plays a role in keeping neurons alive under stress.
On the hormonal side, a retrospective study of bipolar patients found that psychotropic drug treatment was associated with significant changes in thyroid and stress hormones, including decreased cortisol and ACTH levels.32PubMed Central. A Retrospective Study of the Effects of Psychotropic Drugs on Neuroendocrine Hormones in Patients with Bipolar Disorder However, that study looked at psychotropic medications as a group rather than isolating lamotrigine’s specific contribution, so it is difficult to pin down how much of the hormonal shift is attributable to lamotrigine versus other drugs patients were taking. The stress-hormone axis feeds back to the brain in important ways, and sustained reductions in cortisol could theoretically benefit brain regions like the hippocampus that are sensitive to chronic stress exposure. Whether lamotrigine meaningfully moves that needle on its own remains unclear.
The Drug Combination Problem
Much of the research on lamotrigine’s brain effects is complicated by the fact that many patients take it alongside other medications. Valproic acid doubles lamotrigine’s blood levels by slowing its metabolism, which amplifies both therapeutic and side effects. The motor complications, the most dramatic side effects documented in case reports, almost all involved drug combinations rather than lamotrigine alone. Even the cognitive studies can be hard to interpret when patients are on two or three medications, because the cognitive load of the combination may not reflect what lamotrigine itself does.
For people taking lamotrigine as their only neurological or psychiatric medication, the long-term brain profile looks favorable across virtually every measure that has been studied. The cautionary findings, metabolic decreases on brain scans, structural volume changes, rare movement disorders, tend to cluster in combination therapy or in specific populations with underlying brain disease. This is an important distinction for anyone reading about lamotrigine side effects, because the worst-case scenarios in the literature often involve factors well beyond the drug itself.